Jury Awards Blinded Woman $21M Over Sulindac
A federal jury has awarded $21 million to a woman who was blinded and suffered a near-fatal skin disease after taking anti-inflammatory drug Sulindac, dealing a blow to generic-drug company Mutual...To view the full article, register now.
Already a subscriber? Click here to view full article